Learning Objectives
By the end of this session, the learner will be able to identify the four major dopaminergic pathways, explain the clinical consequences of dopamine blockade in each, and describe the physiological link between dopamine and prolactin regulation.
1. The Four Major Pathways
Dopamine (DA) acts as a critical inhibitory neurotransmitter in several distinct circuits within the CNS. Understanding these pathways is essential for predicting the side effects of antipsychotic medications (DA antagonists).
| Pathway | Physiological Function | Clinical Correlation |
|---|---|---|
| Nigrostriatal | Motor control (Substantia Nigra to Striatum). | Degeneration leads to Parkinson’s disease. Blockade causes EPS/Pseudoparkinsonism. |
| Mesolimbic | Arousal, memory, and reinforcement/reward. | Overactivity leads to positive symptoms of psychosis and addiction. |
| Mesocortical | Cognition, affect, and executive function. | Underactivity or blockade leads to negative symptoms (cognitive decline). |
| Tuberoinfundibular | Inhibits Prolactin release from the anterior pituitary. | Blockade leads to Hyperprolactinemia (Gynecomastia, Galactorrhea). |
2. The Chemoreceptor Trigger Zone (CTZ)
Beyond the main tracts, dopamine receptors in the Area Postrema (medulla) play a vital role in the emetic response.
| Action | Drug Type | Clinical Example |
|---|---|---|
| Emesis (Vomiting) | DA Agonists | Apomorphine (used as an emetic). |
| Antiemetic | DA Antagonists | Metoclopramide, Haloperidol. |
3. Endocrine Dysfunction & The “Bridge.”
Dopamine is the primary “Prolactin-Inhibiting Factor.” When DA receptors in the tuberoinfundibular pathway are blocked, prolactin levels rise, disrupting the reproductive axis.
| Step | Hormonal Change | Clinical Result |
|---|---|---|
| 1 | Blockade of DA in the Hypothalamus | Increased Prolactin |
| 2 | High Prolactin levels | Decreased GnRH release. |
| 3 | Low GnRH levels | Decreased FSH & LH production. |
| 4 | Low Gonadotropins | Amenorrhea / Infertility. |
Clinical Pearls:
- Pseudoparkinsonism: Unlike true Parkinson’s, this is reversible once the offending DA antagonist is discontinued.
- Dopamine/ACh Balance: In the striatum, DA normally inhibits ACh. Loss of DA causes an excess of ACh activity, which is why anticholinergics like benztropine help with motor side effects.